Retention Implementation Guide
2.0.0 - ci-build

Retention Implementation Guide - Local Development build (v2.0.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 Artifacts Summary
.... 2.1 Sex Codesystem
.... 2.2 Ethnicity Codesystem
.... 2.3 Country of residence Codesystem
.... 2.4 Marital Status Codesystem
.... 2.5 ABO blood group Codesystem
.... 2.6 Highest level of education Codesystem
.... 2.7 Employment status Codesystem
.... 2.8 Thyroid disease Codesystem
.... 2.9 Smoker Codesystem
.... 2.10 Severe alcohol intake Codesystem
.... 2.11 Cardiomyopathy Codesystem
.... 2.12 NYHA class Codesystem
.... 2.13 Previous coronary revascularization Codesystem
.... 2.14 Atrial fibrillation Codesystem
.... 2.15 Previous valvular intervention Codesystem
.... 2.16 Ventricular stimulation Codesystem
.... 2.17 Type of LVAD Codesystem
.... 2.18 Intention of LVAD Codesystem
.... 2.19 Stroke after LVAD Codesystem
.... 2.20 CMV risk profile Codesystem
.... 2.21 Previous rejection episodes Codesystem
.... 2.22 Allograft vasculopathy Codesystem
.... 2.23 Medication Adherence Codesystem
.... 2.24 Type of visit Codesystem
.... 2.25 Type death Codesystem
.... 2.26 Type of CV admission Codesystem
.... 2.27 Type of rejection Codesystem
.... 2.28 Type of rejection treatment Codesystem
.... 2.29 Dyspnea Codesystem
.... 2.30 Angina Codesystem
.... 2.31 Jugular Venous Pressure Codesystem
.... 2.32 Peripheral edema Codesystem
.... 2.33 Evaluation Codesystem
.... 2.34 Conduction delay Codesystem
.... 2.35 Troponin Codesystem
.... 2.36 Severity Codesystem
.... 2.37 MR Aetiology Codesystem
.... 2.38 VAD alarm Codesystem
.... 2.39 CPET Codesystem
.... 2.40 Questionnaire Symptoms answers Codesystem
.... 2.41 Category Codesystem
.... 2.42 Medication Codesystem
.... 2.43 Helper Codesystem
.... 2.44 Retention Codesystem
.... 2.45 Patient Example
.... 2.46 Arterial Hypertension
.... 2.47 Dyslipidemia
.... 2.48 Diabetes Mellitus type 1
.... 2.49 Diabetes Mellitus type 2
.... 2.50 COPD
.... 2.51 Renal insufficiency
.... 2.52 Estimated glomerular filtration rate
.... 2.53 Cerebrovascular disease
.... 2.54 Peripheral artery disease
.... 2.55 Aortic aneurysm
.... 2.56 Venous thromboembolism / pulmonary embolism
.... 2.57 Carotid Artery Disease
.... 2.58 Cancer
.... 2.59 Anemia
.... 2.60 Thyroid disease
.... 2.61 Benign Prostatic hyperplasia
.... 2.62 Smoker
.... 2.63 Severe alcohol intake
.... 2.64 Date HF diagnosis
.... 2.65 Cardiomyopathy
.... 2.66 NYHA class
.... 2.67 Number of HF admissions during the previous year
.... 2.68 Date HF admission
.... 2.69 Coronary artery disease
.... 2.70 Previous coronary revascularization
.... 2.71 Brady-arrhythmias / AV block
.... 2.72 Ventricular tachycardia / Ventricular fibrillation / Resuscitated sudden death
.... 2.73 Atrial fibrillation
.... 2.74 ICD
.... 2.75 CRT
.... 2.76 Pacemaker
.... 2.77 Previous valvular intervention
.... 2.78 Previous cardiac surgery
.... 2.79 Ventricular stimulation
.... 2.80 Date LVAD implant
.... 2.81 Type of LVAD
.... 2.82 Intention of LVAD
.... 2.83 Stroke after LVAD implantation
.... 2.84 Date stroke
.... 2.85 Gastrointestinal bleeding after LVAD
.... 2.86 Date GI bleeding
.... 2.87 Driveline infections
.... 2.88 Date DL infection
.... 2.89 Right heart failure - One month after implantation
.... 2.90 Right heart failure - At the time of implantation
.... 2.91 Sustained ventricular tachicardia one month after implantation
.... 2.92 Date heart transplant
.... 2.93 CMV risk profile
.... 2.94 CMV infection after transplant
.... 2.95 Previous opportunistic infections
.... 2.96 Previous rejection episodes
.... 2.97 Previous antibody mediated rejection
.... 2.98 Allograft vasculopathy
.... 2.99 Diastolic blood pressure - BP device
.... 2.100 Systolic blood pressure - BP device
.... 2.101 Heart Rate - BP Device
.... 2.102 Heart Rate - Oximeter
.... 2.103 Heart Rate - Average - Smartwatch
.... 2.104 Heart Rate - Maximum - Smartwatch
.... 2.105 Heart Rate - Minimum - Smartwatch
.... 2.106 Peripheral capillary oxygen saturation - Oximeter
.... 2.107 Body weight - Weightscale
.... 2.108 Body Temperature - Smartphone
.... 2.109 Steps - Smartwatch
.... 2.110 Calories - Smartwatch
.... 2.111 Distance - Smartwatch
.... 2.112 Floors climbed - Smartwatch
.... 2.113 Deep sleep time - Smartwatch
.... 2.114 Light sleep time - Smartwatch
.... 2.115 REM sleep - Smartwatch
.... 2.116 Sleep interruptions - Smartwatch
.... 2.117 Medication adherence - Smartphone
.... 2.118 Patient Visit
.... 2.119 Event Death
.... 2.120 Event HF decompensation needing iv. Diuretic
.... 2.121 Event HF decompensation needing inotropes
.... 2.122 Event Heart failure related visit
.... 2.123 Event HF Admission
.... 2.124 Event CV admission other than HF
.... 2.125 Event Other non-CV admissions
.... 2.126 Event Other non-CV visit
.... 2.127 Event Patient category change
.... 2.128 Event Drive line infection
.... 2.129 Event Drive line Reinfection
.... 2.130 Event Infection in other LVAD components
.... 2.131 Event Included in heart transplant list due to drive line infections
.... 2.132 Event Rejection needing treatment in HT
.... 2.133 Event CMV infection requiring medical treatment
.... 2.134 Event Infection
.... 2.135 ACEi Captopril
.... 2.136 ACEi Cilazapril
.... 2.137 ACEi Enalapril
.... 2.138 ACEi Fosinopril
.... 2.139 ACEi Lisinopril
.... 2.140 ACEi Perindopril
.... 2.141 ACEi Quinapril
.... 2.142 ACEi Ramipril
.... 2.143 ACEi Trandolapril
.... 2.144 ARBs Candesartan
.... 2.145 ARBs Losartan
.... 2.146 ARBs Valsartan
.... 2.147 ARBs Olmesartan
.... 2.148 Sacubitril - Valsartan
.... 2.149 Beta-blocker Bisoprolol
.... 2.150 Beta-blocker Carvedilol
.... 2.151 Beta-blocker Metoprolol
.... 2.152 Beta-blocker Nebivolol
.... 2.153 MRA Spironolactone
.... 2.154 MRA Eplerenone
.... 2.155 SGLT2i Canagliflozin
.... 2.156 SGLT2i Dapagliflozin
.... 2.157 SGLT2i Empagliflozin
.... 2.158 SGLT2i Ertugliflozin
.... 2.159 SGLT2i Sotagliflozin
.... 2.160 Ivabradine
.... 2.161 Vericiguat
.... 2.162 Digoxin
.... 2.163 Vasodilators Hydralazine
.... 2.164 Vasodilators Isosorbide dinitrate
.... 2.165 Antiplatelets Aspirin
.... 2.166 Antiplatelets Clopidogrel
.... 2.167 Antiplatelets Prasugrel
.... 2.168 Antiplatelets Ticagrelor
.... 2.169 Anticoagulants Acenocoumarol
.... 2.170 Anticoagulants Apixaban
.... 2.171 Anticoagulants Dabigatran
.... 2.172 Anticoagulants Edoxaban
.... 2.173 Anticoagulants Rivaroxaban
.... 2.174 Anticoagulants Warfarin
.... 2.175 Anticoagulants Phenprocoumon
.... 2.176 Loop diuretics Bumetanide
.... 2.177 Loop diuretics Furosemide
.... 2.178 Loop diuretics Torasemide
.... 2.179 Thiazides Bendroflumethiazide
.... 2.180 Thiazides Chlortalidone
.... 2.181 Thiazides Hydrochlorothiazide
.... 2.182 Thiazides Metolazone
.... 2.183 Thiazides Indapamide
.... 2.184 Potassium sparing diuretics Amiloride
.... 2.185 Potassium sparing diuretics Triamterene
.... 2.186 Potassium supplements Citrate
.... 2.187 Potassium supplements Phosphate
.... 2.188 Potassium supplements Aspartate
.... 2.189 Potassium supplements Bicarbonate
.... 2.190 Potassium supplements Gluconate
.... 2.191 Potassium binders Sodium zirconium cyclosilicate
.... 2.192 Potassium binders Patiromer
.... 2.193 Potassium binders Sodium polystyrene sulfonate
.... 2.194 Statins Atorvastatin
.... 2.195 Statins Fluvastatin
.... 2.196 Statins Lovastatin
.... 2.197 Statins Pravastatin
.... 2.198 Statins Pitavastatin
.... 2.199 Statins Rosuvastatin
.... 2.200 Statins Simvastatin
.... 2.201 Ezetimibe
.... 2.202 Other Antihyperlipidemic Drugs Fibrates
.... 2.203 Other Antihyperlipidemic Drugs Fish oil
.... 2.204 Other Antihyperlipidemic Drugs PCSK9
.... 2.205 Calcium Channel Blockers Amlodipine
.... 2.206 Calcium Channel Blockers Diltiazem
.... 2.207 Calcium Channel Blockers Felodipine
.... 2.208 Calcium Channel Blockers Lacidipine
.... 2.209 Calcium Channel Blockers Nifedipine
.... 2.210 Calcium Channel Blockers Verapamil
.... 2.211 Amiodarone
.... 2.212 Other antiarrhythmics Flecainide
.... 2.213 Other antiarrhythmics Sotalol
.... 2.214 Other antiarrhythmics Mexiletine
.... 2.215 PPI
.... 2.216 Steroids Cortisone
.... 2.217 Steroids Dexamethasone
.... 2.218 Steroids Hydrocortisone
.... 2.219 Steroids Methylprednisolone
.... 2.220 Steroids Prednisolone
.... 2.221 Steroids Prednisone
.... 2.222 Tacrolimus Immediate release (Prograft)
.... 2.223 Tacrolimus Slow release (Advagraft)
.... 2.224 Tacrolimus Extended release (Envarsus)
.... 2.225 Everolimus
.... 2.226 Ciclosporin
.... 2.227 Mycophenolate mofetil
.... 2.228 Mycophenolate sodium
.... 2.229 Antibiotics
.... 2.230 Insulin
.... 2.231 Other Antidiabetics Metformin
.... 2.232 Other Antidiabetics Thiazolidinedione
.... 2.233 Other Antidiabetics Sulfonylurea
.... 2.234 Other Antidiabetics Glucagon-like peptide-1 receptor agonist
.... 2.235 Other Antidiabetics Dipeptidyl peptidase-4 inhibitors
.... 2.236 Other Antidiabetics Alpha-glucosidase inhibitor
.... 2.237 Other drugs
.... 2.238 Dyspnea - Clinical Data
.... 2.239 Angina
.... 2.240 Syncope
.... 2.241 Fatigue - Clinical Data
.... 2.242 Pulmonary rales
.... 2.243 Jugular venous vressure
.... 2.244 Pleural effusion
.... 2.245 Hepatomegaly
.... 2.246 Ascites
.... 2.247 Peripheral edema
.... 2.248 S3
.... 2.249 S4
.... 2.250 Peripheral hypoperfusion
.... 2.251 Peripheral capillary oxygen saturation - Clinical Data
.... 2.252 Body weight - Clinical Data
.... 2.253 Body Temperature - Clinical Data
.... 2.254 Diastolic blood pressure - Clinical Data
.... 2.255 Systolic blood pressure - Clinical Data
.... 2.256 Heart rate - Clinical Data
.... 2.257 Evaluation - Clinical Data
.... 2.258 Sinus rhythm
.... 2.259 Heart rate - ECG
.... 2.260 PQ - PR
.... 2.261 QRS
.... 2.262 QT
.... 2.263 Conduction delay
.... 2.264 Hemoglobin
.... 2.265 Haematocrit
.... 2.266 White Blood Cells
.... 2.267 Platelets
.... 2.268 Urea
.... 2.269 Creatinine
.... 2.270 Uric acid
.... 2.271 Glucose
.... 2.272 Sodium
.... 2.273 Potassium
.... 2.274 Magnesium
.... 2.275 Cholesterol
.... 2.276 Triglycerides
.... 2.277 HDL
.... 2.278 LDL
.... 2.279 ALAT
.... 2.280 ASAT
.... 2.281 gGT
.... 2.282 LDH
.... 2.283 ALP
.... 2.284 Tot prot
.... 2.285 ALB
.... 2.286 Nt pro BNP
.... 2.287 Tbil
.... 2.288 D-Dimer
.... 2.289 Fibrinogen
.... 2.290 INR
.... 2.291 CPK
.... 2.292 CPK - MB
.... 2.293 Troponin
.... 2.294 Calcium
.... 2.295 Phosphorus
.... 2.296 CRP
.... 2.297 PRCLT
.... 2.298 TSH
.... 2.299 fT3
.... 2.300 fT4
.... 2.301 B12
.... 2.302 Iron
.... 2.303 Ferritin
.... 2.304 Evaluation
.... 2.305 Echo date
.... 2.306 LVED diameter
.... 2.307 LVES diameter
.... 2.308 EF
.... 2.309 Basal right ventricle diameter
.... 2.310 TAPSE
.... 2.311 Fractional area change
.... 2.312 Left atrium diameter
.... 2.313 Right atrium area
.... 2.314 AR
.... 2.315 MR
.... 2.316 MR Aetiology
.... 2.317 TR
.... 2.318 AS
.... 2.319 MS
.... 2.320 TS
.... 2.321 RVSP
.... 2.322 Interventricular Septum Thickness
.... 2.323 Left ventricular Posterior wall thickness
.... 2.324 Aortic Root diameter
.... 2.325 Inferior Vena Cava (IVC)
.... 2.326 Cardiac index
.... 2.327 6MWT
.... 2.328 BORG
.... 2.329 Capillary oxygen saturation at beginning
.... 2.330 Capillary oxygen saturation at the end
.... 2.331 VAD flow - Measurement
.... 2.332 VAD speed - Measurement
.... 2.333 VAD PI - Measurement
.... 2.334 VAD power - Measurement
.... 2.335 VAD alarm - Measurement
.... 2.336 CPET
.... 2.337 O2 max
.... 2.338 E to CO2 slope
.... 2.339 METS
.... 2.340 RER
.... 2.341 Questionnaire Response Symptoms
.... 2.342 Questionnaire Response MoCA
.... 2.343 Questionnaire Response MNA
.... 2.344 Questionnaire Response KCCQ
.... 2.345 Questionnaire Response PHQ-9
.... 2.346 Questionnaire Response CBQ-HF
.... 2.347 Questionnaire Response HF-CQ-5
.... 2.348 Patient Retention
.... 2.349 Patient Sex
.... 2.350 Patient Ethnicity
.... 2.351 Patient Country of residence
.... 2.352 Patient Marital Status
.... 2.353 Patient Height
.... 2.354 Patient ABO blood group
.... 2.355 Patient Highest level of education
.... 2.356 Patient Employment status
.... 2.357 Questionnaire Symptoms
.... 2.358 Questionnaire MoCA
.... 2.359 Questionnaire MNA
.... 2.360 Questionnaire KCCQ
.... 2.361 Questionnaire PHQ-9
.... 2.362 Questionnaire CBQHF
.... 2.363 Questionnaire HFCQ5